nodes	percent_of_prediction	percent_of_DWPC	metapath
Irinotecan—lung cancer—melanoma	0.45	1	CtDrD
Irinotecan—ALB—melanoma	0.0648	0.512	CbGaD
Irinotecan—ABCB1—melanoma	0.0619	0.488	CbGaD
Irinotecan—ABCC1—Vemurafenib—melanoma	0.0543	0.191	CbGbCtD
Irinotecan—ABCG2—Vemurafenib—melanoma	0.0363	0.128	CbGbCtD
Irinotecan—ABCC1—Dactinomycin—melanoma	0.0361	0.127	CbGbCtD
Irinotecan—ALB—Vemurafenib—melanoma	0.0251	0.0881	CbGbCtD
Irinotecan—ABCG2—Dactinomycin—melanoma	0.0241	0.0849	CbGbCtD
Irinotecan—ABCC1—Docetaxel—melanoma	0.0186	0.0655	CbGbCtD
Irinotecan—CYP3A4—Temozolomide—melanoma	0.0143	0.0504	CbGbCtD
Irinotecan—ABCC2—Docetaxel—melanoma	0.0138	0.0485	CbGbCtD
Irinotecan—ABCG2—Docetaxel—melanoma	0.0125	0.0439	CbGbCtD
Irinotecan—CYP3A7-CYP3A51P—Docetaxel—melanoma	0.00921	0.0324	CbGbCtD
Irinotecan—CYP3A7—Docetaxel—melanoma	0.00921	0.0324	CbGbCtD
Irinotecan—ABCB1—Dactinomycin—melanoma	0.00871	0.0306	CbGbCtD
Irinotecan—CYP3A4—Vemurafenib—melanoma	0.00785	0.0276	CbGbCtD
Irinotecan—CYP3A5—Docetaxel—melanoma	0.00691	0.0243	CbGbCtD
Irinotecan—ABCB1—Docetaxel—melanoma	0.0045	0.0158	CbGbCtD
Irinotecan—CYP3A4—Docetaxel—melanoma	0.00269	0.00948	CbGbCtD
Irinotecan—Topotecan—ABCB1—melanoma	0.000721	1	CrCbGaD
Irinotecan—TOP1—hair follicle—melanoma	0.000578	0.114	CbGeAlD
Irinotecan—TOP1MT—head—melanoma	0.000311	0.0612	CbGeAlD
Irinotecan—CES1—neck—melanoma	0.00029	0.0571	CbGeAlD
Irinotecan—TOP1—retina—melanoma	0.000286	0.0564	CbGeAlD
Irinotecan—CES2—eye—melanoma	0.000262	0.0516	CbGeAlD
Irinotecan—CES2—retina—melanoma	0.000259	0.0511	CbGeAlD
Irinotecan—ABCC1—hair follicle—melanoma	0.000248	0.0488	CbGeAlD
Irinotecan—TOP1—mammalian vulva—melanoma	0.000229	0.0451	CbGeAlD
Irinotecan—CES2—skin of body—melanoma	0.000228	0.0449	CbGeAlD
Irinotecan—TOP1MT—lymph node—melanoma	0.000217	0.0429	CbGeAlD
Irinotecan—CES2—mammalian vulva—melanoma	0.000208	0.0409	CbGeAlD
Irinotecan—Hypotension—Vemurafenib—melanoma	0.000206	0.00267	CcSEcCtD
Irinotecan—Myocardial infarction—Bleomycin—melanoma	0.000205	0.00266	CcSEcCtD
Irinotecan—Neutropenia—Dactinomycin—melanoma	0.000205	0.00266	CcSEcCtD
Irinotecan—Stomatitis—Bleomycin—melanoma	0.000204	0.00265	CcSEcCtD
Irinotecan—Colitis—Docetaxel—melanoma	0.000202	0.00261	CcSEcCtD
Irinotecan—Abdominal distension—Temozolomide—melanoma	0.0002	0.00259	CcSEcCtD
Irinotecan—Pneumonia—Dactinomycin—melanoma	0.000197	0.00255	CcSEcCtD
Irinotecan—Sweating increased—Temozolomide—melanoma	0.000193	0.0025	CcSEcCtD
Irinotecan—Neutropenia—Carmustine—melanoma	0.000192	0.00249	CcSEcCtD
Irinotecan—Decreased appetite—Vemurafenib—melanoma	0.000192	0.00248	CcSEcCtD
Irinotecan—Stomatitis—Dactinomycin—melanoma	0.00019	0.00247	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Vemurafenib—melanoma	0.00019	0.00247	CcSEcCtD
Irinotecan—Fatigue—Vemurafenib—melanoma	0.00019	0.00246	CcSEcCtD
Irinotecan—Neoplasm—Docetaxel—melanoma	0.00019	0.00246	CcSEcCtD
Irinotecan—Haemoglobin—Bleomycin—melanoma	0.000189	0.00245	CcSEcCtD
Irinotecan—Constipation—Vemurafenib—melanoma	0.000189	0.00244	CcSEcCtD
Irinotecan—Haemorrhage—Bleomycin—melanoma	0.000188	0.00244	CcSEcCtD
Irinotecan—Neutropenia—Temozolomide—melanoma	0.000185	0.0024	CcSEcCtD
Irinotecan—Upper respiratory tract infection—Temozolomide—melanoma	0.000184	0.00239	CcSEcCtD
Irinotecan—Pneumonia—Carmustine—melanoma	0.000184	0.00238	CcSEcCtD
Irinotecan—Sepsis—Docetaxel—melanoma	0.000182	0.00236	CcSEcCtD
Irinotecan—Renal failure—Carmustine—melanoma	0.00018	0.00233	CcSEcCtD
Irinotecan—Weight decreased—Temozolomide—melanoma	0.000179	0.00232	CcSEcCtD
Irinotecan—Stomatitis—Carmustine—melanoma	0.000178	0.00231	CcSEcCtD
Irinotecan—Pneumonia—Temozolomide—melanoma	0.000178	0.0023	CcSEcCtD
Irinotecan—Thrombophlebitis—Docetaxel—melanoma	0.000176	0.00228	CcSEcCtD
Irinotecan—Blood alkaline phosphatase increased—Docetaxel—melanoma	0.000175	0.00227	CcSEcCtD
Irinotecan—Flushing—Bleomycin—melanoma	0.000175	0.00226	CcSEcCtD
Irinotecan—Body temperature increased—Vemurafenib—melanoma	0.000174	0.00226	CcSEcCtD
Irinotecan—Stomatitis—Temozolomide—melanoma	0.000172	0.00223	CcSEcCtD
Irinotecan—Chills—Bleomycin—melanoma	0.000169	0.00219	CcSEcCtD
Irinotecan—Alopecia—Bleomycin—melanoma	0.000166	0.00215	CcSEcCtD
Irinotecan—Haemoglobin—Carmustine—melanoma	0.000165	0.00214	CcSEcCtD
Irinotecan—Haemorrhage—Carmustine—melanoma	0.000164	0.00213	CcSEcCtD
Irinotecan—Flushing—Dactinomycin—melanoma	0.000163	0.00211	CcSEcCtD
Irinotecan—Hypersensitivity—Vemurafenib—melanoma	0.000163	0.00211	CcSEcCtD
Irinotecan—Connective tissue disorder—Carmustine—melanoma	0.000161	0.00209	CcSEcCtD
Irinotecan—Visual disturbance—Docetaxel—melanoma	0.000161	0.00209	CcSEcCtD
Irinotecan—Renal impairment—Docetaxel—melanoma	0.00016	0.00208	CcSEcCtD
Irinotecan—Haemoglobin—Temozolomide—melanoma	0.000159	0.00207	CcSEcCtD
Irinotecan—Haemorrhage—Temozolomide—melanoma	0.000159	0.00206	CcSEcCtD
Irinotecan—Asthenia—Vemurafenib—melanoma	0.000158	0.00205	CcSEcCtD
Irinotecan—Visual impairment—Carmustine—melanoma	0.000158	0.00205	CcSEcCtD
Irinotecan—Chills—Dactinomycin—melanoma	0.000157	0.00204	CcSEcCtD
Irinotecan—Connective tissue disorder—Temozolomide—melanoma	0.000156	0.00202	CcSEcCtD
Irinotecan—Alopecia—Dactinomycin—melanoma	0.000155	0.00201	CcSEcCtD
Irinotecan—Hyponatraemia—Docetaxel—melanoma	0.000153	0.00198	CcSEcCtD
Irinotecan—Visual impairment—Temozolomide—melanoma	0.000153	0.00198	CcSEcCtD
Irinotecan—Gastrointestinal haemorrhage—Docetaxel—melanoma	0.000153	0.00198	CcSEcCtD
Irinotecan—Flushing—Carmustine—melanoma	0.000152	0.00197	CcSEcCtD
Irinotecan—Ill-defined disorder—Bleomycin—melanoma	0.000152	0.00197	CcSEcCtD
Irinotecan—Anaemia—Bleomycin—melanoma	0.000151	0.00196	CcSEcCtD
Irinotecan—Diarrhoea—Vemurafenib—melanoma	0.000151	0.00196	CcSEcCtD
Irinotecan—CES2—head—melanoma	0.000149	0.0293	CbGeAlD
Irinotecan—Malaise—Bleomycin—melanoma	0.000148	0.00191	CcSEcCtD
Irinotecan—Flushing—Temozolomide—melanoma	0.000147	0.00191	CcSEcCtD
Irinotecan—Cardiac disorder—Temozolomide—melanoma	0.000147	0.00191	CcSEcCtD
Irinotecan—Arrhythmia—Carmustine—melanoma	0.000147	0.0019	CcSEcCtD
Irinotecan—Leukopenia—Bleomycin—melanoma	0.000147	0.0019	CcSEcCtD
Irinotecan—Dizziness—Vemurafenib—melanoma	0.000146	0.00189	CcSEcCtD
Irinotecan—Alopecia—Carmustine—melanoma	0.000145	0.00188	CcSEcCtD
Irinotecan—Angiopathy—Temozolomide—melanoma	0.000144	0.00187	CcSEcCtD
Irinotecan—Immune system disorder—Temozolomide—melanoma	0.000143	0.00186	CcSEcCtD
Irinotecan—Mediastinal disorder—Temozolomide—melanoma	0.000143	0.00185	CcSEcCtD
Irinotecan—Cough—Bleomycin—melanoma	0.000143	0.00185	CcSEcCtD
Irinotecan—Chills—Temozolomide—melanoma	0.000142	0.00184	CcSEcCtD
Irinotecan—Dehydration—Docetaxel—melanoma	0.000142	0.00184	CcSEcCtD
Irinotecan—Ill-defined disorder—Dactinomycin—melanoma	0.000142	0.00184	CcSEcCtD
Irinotecan—Anaemia—Dactinomycin—melanoma	0.000141	0.00183	CcSEcCtD
Irinotecan—Vomiting—Vemurafenib—melanoma	0.00014	0.00182	CcSEcCtD
Irinotecan—Alopecia—Temozolomide—melanoma	0.00014	0.00182	CcSEcCtD
Irinotecan—Orthostatic hypotension—Docetaxel—melanoma	0.000139	0.00181	CcSEcCtD
Irinotecan—Rash—Vemurafenib—melanoma	0.000139	0.0018	CcSEcCtD
Irinotecan—Dermatitis—Vemurafenib—melanoma	0.000139	0.0018	CcSEcCtD
Irinotecan—Back pain—Carmustine—melanoma	0.000138	0.00179	CcSEcCtD
Irinotecan—Headache—Vemurafenib—melanoma	0.000138	0.00179	CcSEcCtD
Irinotecan—Discomfort—Bleomycin—melanoma	0.000138	0.00178	CcSEcCtD
Irinotecan—Malaise—Dactinomycin—melanoma	0.000138	0.00178	CcSEcCtD
Irinotecan—Aspartate aminotransferase increased—Docetaxel—melanoma	0.000137	0.00178	CcSEcCtD
Irinotecan—Cramp muscle—Docetaxel—melanoma	0.000137	0.00178	CcSEcCtD
Irinotecan—Leukopenia—Dactinomycin—melanoma	0.000137	0.00177	CcSEcCtD
Irinotecan—Confusional state—Bleomycin—melanoma	0.000135	0.00175	CcSEcCtD
Irinotecan—Anaphylactic shock—Bleomycin—melanoma	0.000134	0.00173	CcSEcCtD
Irinotecan—Oedema—Bleomycin—melanoma	0.000134	0.00173	CcSEcCtD
Irinotecan—Back pain—Temozolomide—melanoma	0.000134	0.00173	CcSEcCtD
Irinotecan—Infection—Bleomycin—melanoma	0.000133	0.00172	CcSEcCtD
Irinotecan—Anaemia—Carmustine—melanoma	0.000132	0.00171	CcSEcCtD
Irinotecan—Nausea—Vemurafenib—melanoma	0.000131	0.0017	CcSEcCtD
Irinotecan—Thrombocytopenia—Bleomycin—melanoma	0.000131	0.0017	CcSEcCtD
Irinotecan—Discomfort—Dactinomycin—melanoma	0.000128	0.00166	CcSEcCtD
Irinotecan—Angina pectoris—Docetaxel—melanoma	0.000128	0.00166	CcSEcCtD
Irinotecan—Ill-defined disorder—Temozolomide—melanoma	0.000128	0.00166	CcSEcCtD
Irinotecan—Leukopenia—Carmustine—melanoma	0.000128	0.00166	CcSEcCtD
Irinotecan—Anaemia—Temozolomide—melanoma	0.000128	0.00165	CcSEcCtD
Irinotecan—Anorexia—Bleomycin—melanoma	0.000127	0.00165	CcSEcCtD
Irinotecan—Hypotension—Bleomycin—melanoma	0.000125	0.00162	CcSEcCtD
Irinotecan—Oedema—Dactinomycin—melanoma	0.000125	0.00161	CcSEcCtD
Irinotecan—Malaise—Temozolomide—melanoma	0.000125	0.00161	CcSEcCtD
Irinotecan—Vertigo—Temozolomide—melanoma	0.000124	0.00161	CcSEcCtD
Irinotecan—Infection—Dactinomycin—melanoma	0.000124	0.0016	CcSEcCtD
Irinotecan—Leukopenia—Temozolomide—melanoma	0.000124	0.0016	CcSEcCtD
Irinotecan—Hypertension—Carmustine—melanoma	0.000123	0.0016	CcSEcCtD
Irinotecan—Neutropenia—Docetaxel—melanoma	0.000123	0.0016	CcSEcCtD
Irinotecan—CES1—head—melanoma	0.000122	0.0241	CbGeAlD
Irinotecan—Thrombocytopenia—Dactinomycin—melanoma	0.000122	0.00158	CcSEcCtD
Irinotecan—Cough—Temozolomide—melanoma	0.000121	0.00156	CcSEcCtD
Irinotecan—Paraesthesia—Bleomycin—melanoma	0.00012	0.00155	CcSEcCtD
Irinotecan—Weight decreased—Docetaxel—melanoma	0.000119	0.00155	CcSEcCtD
Irinotecan—Hypertension—Temozolomide—melanoma	0.000119	0.00155	CcSEcCtD
Irinotecan—Dyspnoea—Bleomycin—melanoma	0.000119	0.00154	CcSEcCtD
Irinotecan—Anorexia—Dactinomycin—melanoma	0.000119	0.00154	CcSEcCtD
Irinotecan—SLC22A3—mammalian vulva—melanoma	0.000119	0.0234	CbGeAlD
Irinotecan—Pneumonia—Docetaxel—melanoma	0.000118	0.00153	CcSEcCtD
Irinotecan—Confusional state—Carmustine—melanoma	0.000118	0.00152	CcSEcCtD
Irinotecan—Oedema—Carmustine—melanoma	0.000117	0.00151	CcSEcCtD
Irinotecan—Discomfort—Temozolomide—melanoma	0.000116	0.00151	CcSEcCtD
Irinotecan—Decreased appetite—Bleomycin—melanoma	0.000116	0.00151	CcSEcCtD
Irinotecan—Infection—Carmustine—melanoma	0.000116	0.0015	CcSEcCtD
Irinotecan—Acute coronary syndrome—Docetaxel—melanoma	0.000116	0.0015	CcSEcCtD
Irinotecan—Renal failure—Docetaxel—melanoma	0.000116	0.0015	CcSEcCtD
Irinotecan—Myocardial infarction—Docetaxel—melanoma	0.000115	0.00149	CcSEcCtD
Irinotecan—TOP1—lymph node—melanoma	0.000115	0.0226	CbGeAlD
Irinotecan—Stomatitis—Docetaxel—melanoma	0.000115	0.00148	CcSEcCtD
Irinotecan—Jaundice—Docetaxel—melanoma	0.000115	0.00148	CcSEcCtD
Irinotecan—Pain—Bleomycin—melanoma	0.000114	0.00148	CcSEcCtD
Irinotecan—Thrombocytopenia—Carmustine—melanoma	0.000114	0.00148	CcSEcCtD
Irinotecan—Confusional state—Temozolomide—melanoma	0.000114	0.00147	CcSEcCtD
Irinotecan—Oedema—Temozolomide—melanoma	0.000113	0.00146	CcSEcCtD
Irinotecan—Anaphylactic shock—Temozolomide—melanoma	0.000113	0.00146	CcSEcCtD
Irinotecan—Infection—Temozolomide—melanoma	0.000112	0.00145	CcSEcCtD
Irinotecan—Anorexia—Carmustine—melanoma	0.000111	0.00144	CcSEcCtD
Irinotecan—Nervous system disorder—Temozolomide—melanoma	0.000111	0.00143	CcSEcCtD
Irinotecan—Thrombocytopenia—Temozolomide—melanoma	0.00011	0.00143	CcSEcCtD
Irinotecan—Feeling abnormal—Bleomycin—melanoma	0.00011	0.00143	CcSEcCtD
Irinotecan—Hypotension—Carmustine—melanoma	0.000109	0.00141	CcSEcCtD
Irinotecan—Hyperhidrosis—Temozolomide—melanoma	0.000109	0.00141	CcSEcCtD
Irinotecan—Decreased appetite—Dactinomycin—melanoma	0.000108	0.0014	CcSEcCtD
Irinotecan—Fatigue—Dactinomycin—melanoma	0.000107	0.00139	CcSEcCtD
Irinotecan—Anorexia—Temozolomide—melanoma	0.000107	0.00139	CcSEcCtD
Irinotecan—Pain—Dactinomycin—melanoma	0.000107	0.00138	CcSEcCtD
Irinotecan—Haemoglobin—Docetaxel—melanoma	0.000106	0.00137	CcSEcCtD
Irinotecan—Rhinitis—Docetaxel—melanoma	0.000106	0.00137	CcSEcCtD
Irinotecan—Body temperature increased—Bleomycin—melanoma	0.000106	0.00137	CcSEcCtD
Irinotecan—Haemorrhage—Docetaxel—melanoma	0.000106	0.00137	CcSEcCtD
Irinotecan—Insomnia—Carmustine—melanoma	0.000106	0.00137	CcSEcCtD
Irinotecan—Paraesthesia—Carmustine—melanoma	0.000105	0.00136	CcSEcCtD
Irinotecan—CES2—lymph node—melanoma	0.000104	0.0205	CbGeAlD
Irinotecan—Dyspnoea—Carmustine—melanoma	0.000104	0.00135	CcSEcCtD
Irinotecan—Somnolence—Carmustine—melanoma	0.000104	0.00134	CcSEcCtD
Irinotecan—Connective tissue disorder—Docetaxel—melanoma	0.000104	0.00134	CcSEcCtD
Irinotecan—Feeling abnormal—Dactinomycin—melanoma	0.000103	0.00133	CcSEcCtD
Irinotecan—Insomnia—Temozolomide—melanoma	0.000102	0.00132	CcSEcCtD
Irinotecan—Gastrointestinal pain—Dactinomycin—melanoma	0.000102	0.00132	CcSEcCtD
Irinotecan—Visual impairment—Docetaxel—melanoma	0.000102	0.00132	CcSEcCtD
Irinotecan—Decreased appetite—Carmustine—melanoma	0.000101	0.00131	CcSEcCtD
Irinotecan—Paraesthesia—Temozolomide—melanoma	0.000101	0.00131	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Carmustine—melanoma	0.000101	0.0013	CcSEcCtD
Irinotecan—Dyspnoea—Temozolomide—melanoma	0.0001	0.0013	CcSEcCtD
Irinotecan—Somnolence—Temozolomide—melanoma	0.0001	0.0013	CcSEcCtD
Irinotecan—Constipation—Carmustine—melanoma	9.97e-05	0.00129	CcSEcCtD
Irinotecan—Pain—Carmustine—melanoma	9.97e-05	0.00129	CcSEcCtD
Irinotecan—Dyspepsia—Temozolomide—melanoma	9.92e-05	0.00129	CcSEcCtD
Irinotecan—Body temperature increased—Dactinomycin—melanoma	9.85e-05	0.00128	CcSEcCtD
Irinotecan—Abdominal pain—Dactinomycin—melanoma	9.85e-05	0.00128	CcSEcCtD
Irinotecan—Hypersensitivity—Bleomycin—melanoma	9.85e-05	0.00128	CcSEcCtD
Irinotecan—ABCC1—mammalian vulva—melanoma	9.81e-05	0.0193	CbGeAlD
Irinotecan—Decreased appetite—Temozolomide—melanoma	9.8e-05	0.00127	CcSEcCtD
Irinotecan—Flushing—Docetaxel—melanoma	9.79e-05	0.00127	CcSEcCtD
Irinotecan—Cardiac disorder—Docetaxel—melanoma	9.79e-05	0.00127	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Temozolomide—melanoma	9.73e-05	0.00126	CcSEcCtD
Irinotecan—Fatigue—Temozolomide—melanoma	9.72e-05	0.00126	CcSEcCtD
Irinotecan—Constipation—Temozolomide—melanoma	9.64e-05	0.00125	CcSEcCtD
Irinotecan—Pain—Temozolomide—melanoma	9.64e-05	0.00125	CcSEcCtD
Irinotecan—Feeling abnormal—Carmustine—melanoma	9.61e-05	0.00125	CcSEcCtD
Irinotecan—Asthenia—Bleomycin—melanoma	9.59e-05	0.00124	CcSEcCtD
Irinotecan—Angiopathy—Docetaxel—melanoma	9.57e-05	0.00124	CcSEcCtD
Irinotecan—Gastrointestinal pain—Carmustine—melanoma	9.54e-05	0.00124	CcSEcCtD
Irinotecan—Immune system disorder—Docetaxel—melanoma	9.53e-05	0.00123	CcSEcCtD
Irinotecan—Mediastinal disorder—Docetaxel—melanoma	9.51e-05	0.00123	CcSEcCtD
Irinotecan—ABCB1—blood vessel—melanoma	9.49e-05	0.0187	CbGeAlD
Irinotecan—Chills—Docetaxel—melanoma	9.47e-05	0.00123	CcSEcCtD
Irinotecan—Arrhythmia—Docetaxel—melanoma	9.43e-05	0.00122	CcSEcCtD
Irinotecan—Alopecia—Docetaxel—melanoma	9.32e-05	0.00121	CcSEcCtD
Irinotecan—Feeling abnormal—Temozolomide—melanoma	9.29e-05	0.0012	CcSEcCtD
Irinotecan—Body temperature increased—Carmustine—melanoma	9.22e-05	0.00119	CcSEcCtD
Irinotecan—Abdominal pain—Carmustine—melanoma	9.22e-05	0.00119	CcSEcCtD
Irinotecan—Gastrointestinal pain—Temozolomide—melanoma	9.22e-05	0.00119	CcSEcCtD
Irinotecan—BCHE—skin of body—melanoma	9.22e-05	0.0182	CbGeAlD
Irinotecan—Hypersensitivity—Dactinomycin—melanoma	9.18e-05	0.00119	CcSEcCtD
Irinotecan—Asthenia—Dactinomycin—melanoma	8.94e-05	0.00116	CcSEcCtD
Irinotecan—Body temperature increased—Temozolomide—melanoma	8.91e-05	0.00115	CcSEcCtD
Irinotecan—Abdominal pain—Temozolomide—melanoma	8.91e-05	0.00115	CcSEcCtD
Irinotecan—Back pain—Docetaxel—melanoma	8.88e-05	0.00115	CcSEcCtD
Irinotecan—Muscle spasms—Docetaxel—melanoma	8.83e-05	0.00114	CcSEcCtD
Irinotecan—Hypersensitivity—Carmustine—melanoma	8.59e-05	0.00111	CcSEcCtD
Irinotecan—ACHE—lymph node—melanoma	8.57e-05	0.0169	CbGeAlD
Irinotecan—CES1—lymph node—melanoma	8.57e-05	0.0169	CbGeAlD
Irinotecan—Diarrhoea—Dactinomycin—melanoma	8.53e-05	0.0011	CcSEcCtD
Irinotecan—Vomiting—Bleomycin—melanoma	8.5e-05	0.0011	CcSEcCtD
Irinotecan—SLC22A3—head—melanoma	8.49e-05	0.0167	CbGeAlD
Irinotecan—Anaemia—Docetaxel—melanoma	8.49e-05	0.0011	CcSEcCtD
Irinotecan—Rash—Bleomycin—melanoma	8.43e-05	0.00109	CcSEcCtD
Irinotecan—Dermatitis—Bleomycin—melanoma	8.42e-05	0.00109	CcSEcCtD
Irinotecan—BCHE—mammalian vulva—melanoma	8.4e-05	0.0166	CbGeAlD
Irinotecan—Asthenia—Carmustine—melanoma	8.37e-05	0.00108	CcSEcCtD
Irinotecan—Hypersensitivity—Temozolomide—melanoma	8.3e-05	0.00108	CcSEcCtD
Irinotecan—Syncope—Docetaxel—melanoma	8.24e-05	0.00107	CcSEcCtD
Irinotecan—Leukopenia—Docetaxel—melanoma	8.22e-05	0.00107	CcSEcCtD
Irinotecan—CYP2B6—skin of body—melanoma	8.22e-05	0.0162	CbGeAlD
Irinotecan—ABCG2—mammalian vulva—melanoma	8.12e-05	0.016	CbGeAlD
Irinotecan—Asthenia—Temozolomide—melanoma	8.09e-05	0.00105	CcSEcCtD
Irinotecan—Loss of consciousness—Docetaxel—melanoma	8.07e-05	0.00105	CcSEcCtD
Irinotecan—Cough—Docetaxel—melanoma	8.02e-05	0.00104	CcSEcCtD
Irinotecan—Diarrhoea—Carmustine—melanoma	7.98e-05	0.00103	CcSEcCtD
Irinotecan—Nausea—Bleomycin—melanoma	7.94e-05	0.00103	CcSEcCtD
Irinotecan—Hypertension—Docetaxel—melanoma	7.93e-05	0.00103	CcSEcCtD
Irinotecan—Vomiting—Dactinomycin—melanoma	7.92e-05	0.00103	CcSEcCtD
Irinotecan—Rash—Dactinomycin—melanoma	7.86e-05	0.00102	CcSEcCtD
Irinotecan—Dizziness—Carmustine—melanoma	7.71e-05	0.001	CcSEcCtD
Irinotecan—Diarrhoea—Temozolomide—melanoma	7.71e-05	0.000999	CcSEcCtD
Irinotecan—Confusional state—Docetaxel—melanoma	7.56e-05	0.000979	CcSEcCtD
Irinotecan—Oedema—Docetaxel—melanoma	7.5e-05	0.000971	CcSEcCtD
Irinotecan—Anaphylactic shock—Docetaxel—melanoma	7.5e-05	0.000971	CcSEcCtD
Irinotecan—Dizziness—Temozolomide—melanoma	7.45e-05	0.000966	CcSEcCtD
Irinotecan—Infection—Docetaxel—melanoma	7.45e-05	0.000965	CcSEcCtD
Irinotecan—Vomiting—Carmustine—melanoma	7.42e-05	0.000961	CcSEcCtD
Irinotecan—Nausea—Dactinomycin—melanoma	7.4e-05	0.000959	CcSEcCtD
Irinotecan—Shock—Docetaxel—melanoma	7.38e-05	0.000956	CcSEcCtD
Irinotecan—Rash—Carmustine—melanoma	7.35e-05	0.000953	CcSEcCtD
Irinotecan—Nervous system disorder—Docetaxel—melanoma	7.35e-05	0.000953	CcSEcCtD
Irinotecan—Dermatitis—Carmustine—melanoma	7.35e-05	0.000952	CcSEcCtD
Irinotecan—Thrombocytopenia—Docetaxel—melanoma	7.34e-05	0.000951	CcSEcCtD
Irinotecan—Headache—Carmustine—melanoma	7.31e-05	0.000947	CcSEcCtD
Irinotecan—Vomiting—Temozolomide—melanoma	7.17e-05	0.000929	CcSEcCtD
Irinotecan—Anorexia—Docetaxel—melanoma	7.15e-05	0.000926	CcSEcCtD
Irinotecan—Rash—Temozolomide—melanoma	7.11e-05	0.000921	CcSEcCtD
Irinotecan—Dermatitis—Temozolomide—melanoma	7.1e-05	0.00092	CcSEcCtD
Irinotecan—Headache—Temozolomide—melanoma	7.06e-05	0.000915	CcSEcCtD
Irinotecan—Hypotension—Docetaxel—melanoma	7e-05	0.000908	CcSEcCtD
Irinotecan—Nausea—Carmustine—melanoma	6.93e-05	0.000898	CcSEcCtD
Irinotecan—Insomnia—Docetaxel—melanoma	6.78e-05	0.000879	CcSEcCtD
Irinotecan—Paraesthesia—Docetaxel—melanoma	6.73e-05	0.000872	CcSEcCtD
Irinotecan—Nausea—Temozolomide—melanoma	6.7e-05	0.000868	CcSEcCtD
Irinotecan—Dyspnoea—Docetaxel—melanoma	6.68e-05	0.000866	CcSEcCtD
Irinotecan—Somnolence—Docetaxel—melanoma	6.66e-05	0.000864	CcSEcCtD
Irinotecan—Dyspepsia—Docetaxel—melanoma	6.6e-05	0.000855	CcSEcCtD
Irinotecan—Decreased appetite—Docetaxel—melanoma	6.52e-05	0.000844	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Docetaxel—melanoma	6.47e-05	0.000839	CcSEcCtD
Irinotecan—Fatigue—Docetaxel—melanoma	6.46e-05	0.000837	CcSEcCtD
Irinotecan—Pain—Docetaxel—melanoma	6.41e-05	0.000831	CcSEcCtD
Irinotecan—Constipation—Docetaxel—melanoma	6.41e-05	0.000831	CcSEcCtD
Irinotecan—Feeling abnormal—Docetaxel—melanoma	6.18e-05	0.0008	CcSEcCtD
Irinotecan—Gastrointestinal pain—Docetaxel—melanoma	6.13e-05	0.000794	CcSEcCtD
Irinotecan—BCHE—head—melanoma	6.01e-05	0.0119	CbGeAlD
Irinotecan—ALB—lymph node—melanoma	5.95e-05	0.0117	CbGeAlD
Irinotecan—SLC22A3—lymph node—melanoma	5.95e-05	0.0117	CbGeAlD
Irinotecan—Abdominal pain—Docetaxel—melanoma	5.93e-05	0.000768	CcSEcCtD
Irinotecan—Body temperature increased—Docetaxel—melanoma	5.93e-05	0.000768	CcSEcCtD
Irinotecan—ABCC2—lymph node—melanoma	5.58e-05	0.011	CbGeAlD
Irinotecan—Hypersensitivity—Docetaxel—melanoma	5.52e-05	0.000716	CcSEcCtD
Irinotecan—Asthenia—Docetaxel—melanoma	5.38e-05	0.000697	CcSEcCtD
Irinotecan—CYP2B6—head—melanoma	5.36e-05	0.0106	CbGeAlD
Irinotecan—Diarrhoea—Docetaxel—melanoma	5.13e-05	0.000665	CcSEcCtD
Irinotecan—ABCB1—retina—melanoma	5e-05	0.00986	CbGeAlD
Irinotecan—Dizziness—Docetaxel—melanoma	4.96e-05	0.000642	CcSEcCtD
Irinotecan—ABCC1—lymph node—melanoma	4.92e-05	0.00969	CbGeAlD
Irinotecan—Vomiting—Docetaxel—melanoma	4.77e-05	0.000618	CcSEcCtD
Irinotecan—Rash—Docetaxel—melanoma	4.73e-05	0.000612	CcSEcCtD
Irinotecan—Dermatitis—Docetaxel—melanoma	4.72e-05	0.000612	CcSEcCtD
Irinotecan—Headache—Docetaxel—melanoma	4.7e-05	0.000609	CcSEcCtD
Irinotecan—Nausea—Docetaxel—melanoma	4.45e-05	0.000577	CcSEcCtD
Irinotecan—BCHE—lymph node—melanoma	4.21e-05	0.0083	CbGeAlD
Irinotecan—ABCG2—lymph node—melanoma	4.07e-05	0.00802	CbGeAlD
Irinotecan—ABCB1—mammalian vulva—melanoma	4.01e-05	0.0079	CbGeAlD
Irinotecan—ABCB1—head—melanoma	2.87e-05	0.00565	CbGeAlD
Irinotecan—ABCB1—lymph node—melanoma	2.01e-05	0.00396	CbGeAlD
Irinotecan—ABCG2—Metabolism—ABCB1—melanoma	3.8e-06	6.82e-05	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—PIK3CD—melanoma	3.8e-06	6.82e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	3.8e-06	6.81e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—GNA11—melanoma	3.8e-06	6.81e-05	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—PIK3CA—melanoma	3.78e-06	6.78e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PRKCA—melanoma	3.78e-06	6.78e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—ABCB1—melanoma	3.77e-06	6.76e-05	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—ALB—melanoma	3.75e-06	6.73e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—ERCC2—melanoma	3.75e-06	6.72e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—CD80—melanoma	3.73e-06	6.68e-05	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	3.72e-06	6.67e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—APC—melanoma	3.72e-06	6.67e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—KIT—melanoma	3.72e-06	6.67e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—FASN—melanoma	3.72e-06	6.66e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—GNA11—melanoma	3.71e-06	6.66e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—EGF—melanoma	3.68e-06	6.59e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—PIK3CD—melanoma	3.67e-06	6.58e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PPARG—melanoma	3.67e-06	6.57e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—SLC5A5—melanoma	3.66e-06	6.55e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PIP4K2A—melanoma	3.63e-06	6.51e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—SLC6A11—melanoma	3.63e-06	6.51e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—FASN—melanoma	3.63e-06	6.51e-05	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	3.6e-06	6.46e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—SLC5A5—melanoma	3.57e-06	6.41e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.57e-06	6.4e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—MTAP—melanoma	3.53e-06	6.34e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—GNAQ—melanoma	3.53e-06	6.33e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—CD44—melanoma	3.53e-06	6.33e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—VCAN—melanoma	3.52e-06	6.3e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PRKCA—melanoma	3.5e-06	6.27e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—BRAF—melanoma	3.5e-06	6.27e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—ERCC2—melanoma	3.47e-06	6.22e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PRKCA—melanoma	3.47e-06	6.22e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—CD44—melanoma	3.45e-06	6.19e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—GNAQ—melanoma	3.45e-06	6.19e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—ERCC2—melanoma	3.44e-06	6.17e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PIK3CG—melanoma	3.41e-06	6.1e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.39e-06	6.08e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—CYP17A1—melanoma	3.39e-06	6.07e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—CYP1B1—melanoma	3.39e-06	6.07e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	3.34e-06	5.99e-05	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—PIK3CB—melanoma	3.32e-06	5.94e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—CYP1B1—melanoma	3.31e-06	5.93e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—MAP2K1—melanoma	3.29e-06	5.9e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PPARG—melanoma	3.29e-06	5.89e-05	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—PTGS2—melanoma	3.28e-06	5.89e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—PIK3CD—melanoma	3.27e-06	5.86e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.27e-06	5.86e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PIK3CG—melanoma	3.23e-06	5.79e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PIK3CG—melanoma	3.23e-06	5.79e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—GNA11—melanoma	3.2e-06	5.73e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—PIK3CB—melanoma	3.2e-06	5.73e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.19e-06	5.71e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PHGDH—melanoma	3.15e-06	5.65e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—LUM—melanoma	3.15e-06	5.65e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—FGF2—melanoma	3.13e-06	5.61e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—FASN—melanoma	3.13e-06	5.61e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PPARG—melanoma	3.12e-06	5.59e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PPARG—melanoma	3.12e-06	5.59e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PIK3CG—melanoma	3.12e-06	5.59e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.11e-06	5.57e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—HPSE—melanoma	3.09e-06	5.54e-05	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—AKT1—melanoma	3.09e-06	5.54e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—SLC5A5—melanoma	3.08e-06	5.52e-05	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	3.04e-06	5.45e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PIK3CG—melanoma	3.04e-06	5.45e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CUBN—melanoma	3.03e-06	5.44e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PPARG—melanoma	3.01e-06	5.39e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PIK3CD—melanoma	2.99e-06	5.37e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—GNAQ—melanoma	2.97e-06	5.33e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—CD44—melanoma	2.97e-06	5.33e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CYP17A1—melanoma	2.97e-06	5.32e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PIK3CG—melanoma	2.96e-06	5.31e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—ALB—melanoma	2.96e-06	5.3e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—IL2—melanoma	2.94e-06	5.26e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PPARG—melanoma	2.93e-06	5.26e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—MDM2—melanoma	2.93e-06	5.25e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—SDHD—melanoma	2.93e-06	5.25e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—BSG—melanoma	2.93e-06	5.25e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CSPG4—melanoma	2.93e-06	5.25e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.91e-06	5.22e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—ERBB2—melanoma	2.89e-06	5.18e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PTGS2—melanoma	2.88e-06	5.17e-05	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—PTEN—melanoma	2.86e-06	5.13e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PPARG—melanoma	2.86e-06	5.12e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—PIK3CB—melanoma	2.85e-06	5.11e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—CYP1B1—melanoma	2.85e-06	5.11e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—CD4—melanoma	2.85e-06	5.1e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PIK3CD—melanoma	2.84e-06	5.09e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PIK3CD—melanoma	2.84e-06	5.09e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GPAM—melanoma	2.84e-06	5.08e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—PTGS2—melanoma	2.82e-06	5.06e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—ALB—melanoma	2.8e-06	5.03e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—ALB—melanoma	2.8e-06	5.03e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—GNA11—melanoma	2.8e-06	5.02e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—ABCB1—melanoma	2.79e-06	5e-05	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	2.75e-06	4.92e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PIK3CG—melanoma	2.74e-06	4.91e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—FASN—melanoma	2.74e-06	4.91e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PIK3CD—melanoma	2.74e-06	4.91e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—ABCB1—melanoma	2.73e-06	4.88e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PIK3CG—melanoma	2.72e-06	4.87e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—ALB—melanoma	2.7e-06	4.85e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—SLC5A5—melanoma	2.7e-06	4.83e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—CDKN1B—melanoma	2.68e-06	4.8e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PIK3CD—melanoma	2.67e-06	4.79e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PPARG—melanoma	2.65e-06	4.74e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—ALB—melanoma	2.64e-06	4.73e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PPARG—melanoma	2.62e-06	4.7e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PIK3CB—melanoma	2.61e-06	4.68e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—GNAQ—melanoma	2.6e-06	4.67e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CD44—melanoma	2.6e-06	4.67e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PIK3CD—melanoma	2.6e-06	4.67e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PTGS2—melanoma	2.59e-06	4.63e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—ALB—melanoma	2.57e-06	4.61e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PRKCA—melanoma	2.57e-06	4.6e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—ERCC2—melanoma	2.54e-06	4.56e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—CTNNB1—melanoma	2.53e-06	4.53e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.52e-06	4.51e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PRKCA—melanoma	2.51e-06	4.5e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CYP1B1—melanoma	2.5e-06	4.48e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—VEGFA—melanoma	2.5e-06	4.47e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—ERCC2—melanoma	2.49e-06	4.46e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PIK3CB—melanoma	2.48e-06	4.44e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PIK3CB—melanoma	2.48e-06	4.44e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—CDKN1A—melanoma	2.47e-06	4.43e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—NRAS—melanoma	2.47e-06	4.42e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—PTEN—melanoma	2.46e-06	4.42e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PTGS2—melanoma	2.45e-06	4.4e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PTGS2—melanoma	2.45e-06	4.4e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PLA2G6—melanoma	2.41e-06	4.32e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PIK3CD—melanoma	2.41e-06	4.32e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PIK3CD—melanoma	2.39e-06	4.28e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PIK3CB—melanoma	2.39e-06	4.28e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—ALB—melanoma	2.38e-06	4.27e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PTGS2—melanoma	2.37e-06	4.24e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—MAPK3—melanoma	2.36e-06	4.23e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—ALB—melanoma	2.36e-06	4.23e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—ABCB1—melanoma	2.35e-06	4.21e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PIK3CB—melanoma	2.33e-06	4.17e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PTGS2—melanoma	2.31e-06	4.13e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PIK3CB—melanoma	2.27e-06	4.07e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PTEN—melanoma	2.25e-06	4.04e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PTGS2—melanoma	2.25e-06	4.03e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—MAPK1—melanoma	2.25e-06	4.03e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—STAT3—melanoma	2.2e-06	3.95e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—NRAS—melanoma	2.2e-06	3.94e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—VCAN—melanoma	2.17e-06	3.88e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PRKCA—melanoma	2.16e-06	3.87e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—ERCC2—melanoma	2.14e-06	3.84e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PTEN—melanoma	2.14e-06	3.84e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PTEN—melanoma	2.14e-06	3.84e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—KRAS—melanoma	2.12e-06	3.8e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—MAPK3—melanoma	2.1e-06	3.77e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PIK3CB—melanoma	2.1e-06	3.77e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PIK3CB—melanoma	2.08e-06	3.73e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PTGS2—melanoma	2.08e-06	3.73e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PTGS2—melanoma	2.06e-06	3.7e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PTEN—melanoma	2.06e-06	3.7e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—MYC—melanoma	2.05e-06	3.67e-05	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—PIK3CA—melanoma	2.02e-06	3.62e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PTEN—melanoma	2.01e-06	3.61e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PIK3CG—melanoma	2.01e-06	3.6e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—MAPK1—melanoma	2e-06	3.59e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—EGFR—melanoma	2e-06	3.59e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PIK3CG—melanoma	1.96e-06	3.52e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PTEN—melanoma	1.96e-06	3.51e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—PIK3CA—melanoma	1.95e-06	3.49e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PPARG—melanoma	1.94e-06	3.48e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PPARG—melanoma	1.9e-06	3.4e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PRKCA—melanoma	1.89e-06	3.39e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—KRAS—melanoma	1.89e-06	3.39e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—TP53—melanoma	1.89e-06	3.38e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—ERCC2—melanoma	1.88e-06	3.36e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CYP17A1—melanoma	1.83e-06	3.28e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PTEN—melanoma	1.82e-06	3.25e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—HRAS—melanoma	1.8e-06	3.23e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PTEN—melanoma	1.8e-06	3.23e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.77e-06	3.18e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PIK3CD—melanoma	1.77e-06	3.17e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—ALB—melanoma	1.74e-06	3.13e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—PIK3CA—melanoma	1.74e-06	3.12e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PIK3CD—melanoma	1.73e-06	3.1e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GNA11—melanoma	1.73e-06	3.09e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—ALB—melanoma	1.7e-06	3.06e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PIK3CG—melanoma	1.69e-06	3.03e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—FASN—melanoma	1.69e-06	3.03e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—SLC5A5—melanoma	1.66e-06	2.98e-05	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—AKT1—melanoma	1.65e-06	2.96e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PPARG—melanoma	1.63e-06	2.93e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—HRAS—melanoma	1.61e-06	2.88e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GNAQ—melanoma	1.6e-06	2.88e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CD44—melanoma	1.6e-06	2.88e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—AKT1—melanoma	1.59e-06	2.85e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PIK3CA—melanoma	1.59e-06	2.85e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PIK3CB—melanoma	1.54e-06	2.76e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—IL6—melanoma	1.54e-06	2.76e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CYP1B1—melanoma	1.54e-06	2.76e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PTGS2—melanoma	1.53e-06	2.74e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PIK3CA—melanoma	1.51e-06	2.71e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PIK3CA—melanoma	1.51e-06	2.71e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PIK3CB—melanoma	1.51e-06	2.7e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PTGS2—melanoma	1.49e-06	2.67e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PIK3CD—melanoma	1.49e-06	2.67e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PIK3CG—melanoma	1.48e-06	2.66e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PIK3CA—melanoma	1.46e-06	2.61e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PPARG—melanoma	1.43e-06	2.56e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—AKT1—melanoma	1.42e-06	2.54e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PIK3CA—melanoma	1.42e-06	2.54e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PIK3CA—melanoma	1.38e-06	2.48e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PTEN—melanoma	1.33e-06	2.39e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PIK3CD—melanoma	1.3e-06	2.34e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PTEN—melanoma	1.3e-06	2.33e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—AKT1—melanoma	1.3e-06	2.33e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PIK3CB—melanoma	1.3e-06	2.32e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—ALB—melanoma	1.29e-06	2.31e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PTGS2—melanoma	1.28e-06	2.3e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PIK3CA—melanoma	1.28e-06	2.3e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PIK3CA—melanoma	1.27e-06	2.28e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ABCB1—melanoma	1.27e-06	2.27e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—AKT1—melanoma	1.23e-06	2.21e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—AKT1—melanoma	1.23e-06	2.21e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—AKT1—melanoma	1.19e-06	2.13e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PRKCA—melanoma	1.17e-06	2.09e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—AKT1—melanoma	1.16e-06	2.08e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ERCC2—melanoma	1.16e-06	2.07e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PIK3CB—melanoma	1.14e-06	2.04e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—AKT1—melanoma	1.13e-06	2.03e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PTGS2—melanoma	1.13e-06	2.02e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PTEN—melanoma	1.12e-06	2.01e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—AKT1—melanoma	1.05e-06	1.88e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—AKT1—melanoma	1.04e-06	1.86e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PTEN—melanoma	9.82e-07	1.76e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PIK3CA—melanoma	9.39e-07	1.68e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PIK3CA—melanoma	9.18e-07	1.64e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PIK3CG—melanoma	9.13e-07	1.64e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PPARG—melanoma	8.81e-07	1.58e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PIK3CD—melanoma	8.03e-07	1.44e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ALB—melanoma	7.93e-07	1.42e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PIK3CA—melanoma	7.9e-07	1.42e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—AKT1—melanoma	7.67e-07	1.37e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—AKT1—melanoma	7.5e-07	1.34e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PIK3CB—melanoma	7e-07	1.25e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PTGS2—melanoma	6.93e-07	1.24e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PIK3CA—melanoma	6.92e-07	1.24e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—AKT1—melanoma	6.46e-07	1.16e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PTEN—melanoma	6.05e-07	1.08e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—AKT1—melanoma	5.66e-07	1.01e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PIK3CA—melanoma	4.27e-07	7.65e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—AKT1—melanoma	3.49e-07	6.25e-06	CbGpPWpGaD
